Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

SUN Ying, WANG Jingwen, SHI Guobing. Pharmacoeconomics analysis of two treatment schemes in decompensated cirrhosis patients[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 80-82. doi: 10.3969/j.issn.1006-0111.2015.01.023
Citation: SUN Ying, WANG Jingwen, SHI Guobing. Pharmacoeconomics analysis of two treatment schemes in decompensated cirrhosis patients[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 80-82. doi: 10.3969/j.issn.1006-0111.2015.01.023

Pharmacoeconomics analysis of two treatment schemes in decompensated cirrhosis patients

doi: 10.3969/j.issn.1006-0111.2015.01.023
  • Received Date: 2013-08-30
  • Rev Recd Date: 2014-04-14
  • Objective To evaluate two treatment schemes of liver protection and choose the optimal radiotherapy using pharmacoeconomics principle and methods. Methods In-patients who were diagnosed as decompensated cirrhosis patients and simultaneously conformed to the Chlid-Pugh graduation of level B-C during 2010-2012 were chosen.The chosen patients were divided into A,B and C group separately,and were treated with the compound prescription of dichloro acetic acid two isopropyl amine inoculation fluid,the polyene phosphatide acid radical choline inoculation fluid,and the compound prescription dichloro acetic acid two isopropyl amine inoculation fluid and the polyene phosphatide acid radical choline inoculation fluid.Cost effectiveness analysis was done between group B and C. Results Treatment time of group B and C was (15.5±8.55) d and (12.13±7.61) d respectively.The total effectiveness was 50% and 60% respectively and the difference was with non-statistics significance (P>0.05).The total cost was (1 640.52±905.26) yuan and (2 576.51±1 615.99) yuan respectively. Conclusion Group B was the better treatment scheme.
  • [1] 萧焕明,施梅姐,池晓玲.373例乙肝肝硬化失代偿期患者证候与客观指标的相关性研究[J].辽宁中医杂志,2012,39(10):1909-1912.
    [2] Fattovich G,Bortolotti F,Donato F.History of chronic hepatitis B:special emphasis on disease progression and prognostic factors[J].J Hepatol,2008,48(2):335-352.
    [3] 中国中西医结合学会消化系统疾病专业委员会.肝硬化中西医结合诊治方案诊断标准(共识意见)[J].现代消化及介入诊疗,2006,10(2):119-120.
    [4] 孙桂君,王 艳.6种用药方案治疗化疗药物相关性肝损害的经济学评价[J].中国药房,2009,20(17):1281-1284.
    [5] 胡善联.药物经济学[M].北京:高等教育出版社,2009:31-43.
    [6] 杨 楠,戴媛媛,费小非.晚期大肠癌3种化疗方案的最小成本分析[J].中国药房,2010,21(14):1267-1268.
    [7] 胡嘉坤,李建权,张晓曼,等.3种用药方案治疗冠心病心绞痛的最小成本分析[J].中国药房,2009,20(32):2487-2489.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2544) PDF downloads(77) Cited by()

Related
Proportional views

Pharmacoeconomics analysis of two treatment schemes in decompensated cirrhosis patients

doi: 10.3969/j.issn.1006-0111.2015.01.023

Abstract: Objective To evaluate two treatment schemes of liver protection and choose the optimal radiotherapy using pharmacoeconomics principle and methods. Methods In-patients who were diagnosed as decompensated cirrhosis patients and simultaneously conformed to the Chlid-Pugh graduation of level B-C during 2010-2012 were chosen.The chosen patients were divided into A,B and C group separately,and were treated with the compound prescription of dichloro acetic acid two isopropyl amine inoculation fluid,the polyene phosphatide acid radical choline inoculation fluid,and the compound prescription dichloro acetic acid two isopropyl amine inoculation fluid and the polyene phosphatide acid radical choline inoculation fluid.Cost effectiveness analysis was done between group B and C. Results Treatment time of group B and C was (15.5±8.55) d and (12.13±7.61) d respectively.The total effectiveness was 50% and 60% respectively and the difference was with non-statistics significance (P>0.05).The total cost was (1 640.52±905.26) yuan and (2 576.51±1 615.99) yuan respectively. Conclusion Group B was the better treatment scheme.

SUN Ying, WANG Jingwen, SHI Guobing. Pharmacoeconomics analysis of two treatment schemes in decompensated cirrhosis patients[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 80-82. doi: 10.3969/j.issn.1006-0111.2015.01.023
Citation: SUN Ying, WANG Jingwen, SHI Guobing. Pharmacoeconomics analysis of two treatment schemes in decompensated cirrhosis patients[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 80-82. doi: 10.3969/j.issn.1006-0111.2015.01.023
Reference (7)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return